Rating History for Genmab A/S (GMAB) by Jefferies
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/17/2026 | Benjamin Jackson | New Coverage | Buy (N/A) |
41.50 (N/A) |
29.59 (27.06) |
-8.55% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/17/2026 | Benjamin Jackson | New Coverage | Buy (N/A) |
41.50 (N/A) |
29.59 (27.06) |
-8.55% | Details |
![]() |
|||||||